Gene · 407014
Papers3,611
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 3,611
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of Oxidative Stress in the Pathogenesis of Vitiligo: A Culprit for Melanocyte Death. | Oxid Med Cell Longev | 2022 | 35103096 | PubTator, text mining | PubMed |
| Epigenetic Changes and Functions in Pneumoconiosis. | Oxid Med Cell Longev | 2022 | 35096264 | PubTator, text mining | PubMed |
| Insights into N6-methyladenosine and programmed cell death in cancer. | Mol Cancer | 2022 | 35090469 | PubTator, text mining | PubMed |
| Epi-miRNAs: Regulators of the Histone Modification Machinery in Human Cancer. | J Oncol | 2022 | 35087589 | PubTator, text mining | PubMed |
| Tanshinone IIA attenuates the stemness of breast cancer cells via targeting the miR-125b/STARD13 axis. | Exp Hematol Oncol | 2022 | 35057866 | PubTator, text mining | PubMed |
| Impact of Inherited Genetic Variants on Critically Ill Septic Children. | Pathogens | 2022 | 35056044 | PubTator, text mining | PubMed |
| Anti-miR-135/SPOCK1 axis antagonizes the influence of metabolism on drug response in intestinal/colon tumour organoids. | Oncogenesis | 2022 | 35046388 | PubTator, text mining | PubMed |
| Highly-metastatic colorectal cancer cell released miR-181a-5p-rich extracellular vesicles promote liver metastasis by activating hepatic stellate cells and remodelling the tumour microenvironment. | J Extracell Vesicles | 2022 | 35041299 | PubTator, text mining | PubMed |
| A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer. | J Ovarian Res | 2022 | 35031063 | PubTator, text mining | PubMed |
| SUMOylation inhibition enhances dexamethasone sensitivity in multiple myeloma. | J Exp Clin Cancer Res | 2022 | 34983615 | PubTator, text mining | PubMed |
| Curcumin alters distinct molecular pathways in breast cancer subtypes revealed by integrated miRNA/mRNA expression analysis. | Cancer Rep (Hoboken) | 2022 | 34981672 | PubTator, text mining | PubMed |
| Increased expression of six-large extracellular vesicle-derived miRNAs signature for nonvalvular atrial fibrillation. | J Transl Med | 2022 | 34980172 | PubTator, text mining | PubMed |
| Long non-coding RNA MAGI2-AS3 inactivates STAT3 pathway to inhibit prostate cancer cell proliferation via acting as a microRNA-424-5p sponge. | J Cancer | 2022 | 34976194 | PubTator, text mining | PubMed |
| lnc‑MICAL2‑1 sponges miR‑25 to regulate DKK3 expression and inhibits activation of the Wnt/β‑catenin signaling pathway in breast cancer. | Int J Mol Med | 2022 | 34970696 | PubTator, text mining | PubMed |
| Hypoplastic myelodysplastic syndrome and acquired aplastic anemia: Immune‑mediated bone marrow failure syndromes (Review). | Int J Oncol | 2022 | 34958107 | PubTator, text mining | PubMed |
| What if the future of HER2-positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO study. | Cancer Med | 2022 | 34921525 | PubTator, text mining | PubMed |
| Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case-control study. | Arch Gynecol Obstet | 2022 | 34889994 | PubTator, text mining | PubMed |
| Barrett's esophagus: The pathomorphological and molecular genetic keystones of neoplastic progression. | Cancer Med | 2022 | 34870375 | PubTator, text mining | PubMed |
| Docetaxel-triggered SIDT2/NOX4/JNK/HuR signaling axis is associated with TNF-α-mediated apoptosis of cancer cells. | Biochem Pharmacol | 2022 | 34863979 | PubTator, text mining | PubMed |
| Non-coding RNAs underlying the pathophysiological links between type 2 diabetes and pancreatic cancer: A systematic review. | J Diabetes Investig | 2022 | 34859606 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407014/papers?page=40